We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.2%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43.6B
AUM Growth
+$2.01B
(+4.8%)
Cap. Flow
+$1.75B
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
18.28%
Holding
1,493
New
278
Increased
387
Reduced
400
Closed
399
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$674M |
| 2 |
IBM
IBM
|
+$408M |
| 3 |
Toronto Dominion Bank
TD
|
+$392M |
| 4 |
Biogen
BIIB
|
+$340M |
| 5 |
Boeing
BA
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$366M |
| 2 |
CVS Health
CVS
|
+$350M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$333M |
| 4 |
TSMC
TSM
|
+$323M |
| 5 |
Merck
MRK
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 17.17% |
| 3 | Financials | 16.49% |
| 4 | Consumer Discretionary | 12.16% |
| 5 | Industrials | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Carter's
CRI
$1.47B
| $54.3M | 0.12% |
521,537
+457,316
| +712% | +$53.2M |
|
|
WCG
177
DELISTED
Wellcare Health Plans, Inc.
WCG
| $53.4M | 0.12% |
275,943
+26,994
| +11% | +$5.41M |
|
|
UN
178
DELISTED
Unilever NV New York Registry Shares
UN
| $53.3M | 0.12% |
944,565
+237,818
| +34% | +$13.1M |
|
179
Darden Restaurants
DRI
$24.4B
| $53.2M | 0.12% |
624,453
+362,165
| +138% | +$34.3M |
|
180
Check Point Software Technologies
CHKP
$13.1B
| $53.1M | 0.12% |
534,054
-657,457
| -55% | -$67.7M |
|
181
PNC Financial Services
PNC
$101B
| $52.9M | 0.12% |
349,447
-310,689
| -47% | -$48.2M |
|
|
ALXN
182
DELISTED
Alexion Pharmaceuticals
ALXN
| $52.8M | 0.12% |
474,114
+163,214
| +52% | +$19.5M |
|
183
STMicroelectronics
STM
$50B
| $52.8M | 0.12% |
2,370,476
-4,700,403
| -66% | -$110M |
|
|
QVCGA
184
DELISTED
QVC Group Inc Series A
QVCGA
| $52.2M | 0.12% |
42,710
+25,634
| +150% | +$33.7M |
|
|
BIG
185
DELISTED
Big Lots, Inc.
BIG
| $51.9M | 0.12% |
1,193,176
+737,282
| +162% | +$40.4M |
|
186
BWX Technologies
BWXT
$15.6B
| $51.7M | 0.12% |
813,765
-196,231
| -19% | -$12.4M |
|
187
lululemon athletica
LULU
$14.6B
| $51.3M | 0.12% |
575,842
+180,101
| +46% | +$14.4M |
|
188
Dominion Energy
D
$59.3B
| $51.2M | 0.12% |
+759,800
| New | +$56.1M |
|
|
CEO
189
DELISTED
CNOOC Limited
CEO
| $51M | 0.12% |
+344,750
| New | +$51.8M |
|
190
Phillips 66
PSX
$81.4B
| $50.6M | 0.12% |
527,900
+502,800
| +2,003% | +$48.9M |
|
191
Jack Henry & Associates
JKHY
$11.1B
| $50.2M | 0.12% |
415,147
+77,921
| +23% | +$9.48M |
|
192
Walmart Inc
WMT
$890B
| $49.7M | 0.11% |
1,676,400
+1,629,300
| +3,459% | +$52.4M |
|
193
Palo Alto Networks
PANW
$297B
| $49.7M | 0.11% |
+1,642,800
| New | +$45.6M |
|
194
LPL Financial
LPLA
$28.6B
| $49.5M | 0.11% |
810,814
+372,436
| +85% | +$23.1M |
|
195
Waters Corp
WAT
$39.9B
| $47.4M | 0.11% |
238,466
-317,999
| -57% | -$65.8M |
|
196
Annaly Capital Management
NLY
$17.4B
| $47M | 0.11% |
1,125,623
-17,175
| -2% | -$732K |
|
197
Exelixis
EXEL
$13.4B
| $46.9M | 0.11% |
2,119,065
+275,936
| +15% | +$7.63M |
|
198
Hilton Grand Vacations
HGV
$3.55B
| $46.9M | 0.11% |
1,089,456
-51,715
| -5% | -$2.27M |
|
199
Five Below
FIVE
$13.5B
| $46.3M | 0.11% |
630,989
+562,889
| +827% | +$37.9M |
|
200
Edwards Lifesciences
EW
$51.7B
| $45.2M | 0.1% |
972,714
+630,318
| +184% | +$27.4M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2018 Portfolio in Review
As of Q1 2018, Arrowstreet Capital held 1,493 positions worth $43.6B, up 4.8% from $41.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital deployed $1.75B of net new capital in Q1 2018, opening 278 new positions and adding to 387 existing holdings. Its largest new stake was AB InBev: 2,063,707 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Philip Morris, an estimated $366M trimmed.
- Arrowstreet Capital's largest Q1 2018 buy was AB InBev: 2,063,707 shares worth $227M.
- Arrowstreet Capital added most to AbbVie in Q1 2018, an estimated $674M increase.
- Arrowstreet Capital's biggest Q1 2018 reduction was Philip Morris, cutting an estimated $366M.
- Arrowstreet Capital fully exited iShares MSCI South Korea ETF in Q1 2018, selling an estimated $271M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $43.6B portfolio in Q1 2018.
- Arrowstreet Capital opened 278 new positions and closed 399 in Q1 2018.
- Arrowstreet Capital's portfolio value rose 4.8% quarter-over-quarter to $43.6B.
Based on Arrowstreet Capital's 13F filing for Q1 2018, filed 14 May 2018.